Management of Chronic Kidney Disease

In the general population, there is insufficient evidence to recommend for or against periodic evaluation for chronic kidney disease. ()

When screening or stratifying risk for chronic kidney disease, we recommend including urine albumin-to-creatinine ratio testing in addition to estimated glomerular filtration rate to optimize the diagnosis and staging of chronic kidney disease. (Strong for)

In patients with an estimated glomerular filtration rate <60 mL/minute/1.73 m², we suggest one-time cystatin C-based estimated glomerular filtration to confirm diagnosis and/or refine staging of chronic kidney disease. (Weak for)

We suggest the use of a validated risk prediction model as a clinical decision support aid in the management of patients with chronic kidney disease. (Weak for)

When assessing the risk of progression to end-stage renal disease, there is insufficient evidence to recommend a specific risk prediction calculator. ()